Dr. Venkatesh Nadar

Arun R. Kanmanthareddy, MD, specializes in structural heart disease cardiology and interventional cardiology and is board-certified in interventional cardiology, internal medicine, and cardiovascular disease by the American Board of Internal Medicine. He is affiliated with UPMC Community Osteopathic, UPMC Lititz, UPMC Carlisle, UPMC West Shore and UPMC Pinnacle Harrisburg. Dr. Kanmanthareddy completed his fellowships at the University of Texas Health Science Center at Houston, Mount Sinai Icahn School of Medicine and Creighton University Medical Center, residency at Crozer-Chester Medical Center and medical degree at Armed Forces Medical College. Dr. Kanmantha is rated as an Advanced provider by MediFind in the treatment of Brugada Syndrome. His top areas of expertise are Aortic Valve Stenosis, Brugada Syndrome, Short QT Syndrome, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

Dr. Michael J. Blaha MD MPH is Professor of Cardiology and Epidemiology and presently serves as the Director of Clinical Research for the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Director of the Cardiometabolic Clinic, and Program Director for the Preventive Cardiology Fellowship. His clinical interests include primary and secondary prevention of cardiovascular disease, with emphasis on early intervention in patients with advanced subclinical atherosclerosis detected with cardiac computed tomography. Dr. Blaha represents the 4th generation of physicians in his family. After earning a BS in pre-medical studies and classical civilization at the University of Notre Dame in 2001, Dr. Blaha went to Vanderbilt University where in 2006 he received his MD as well as an MPH. in clinical epidemiology and biostatistics. Dr. Blaha then completed his Internal Medicine residency in the Osler Medical Housestaff Training Program at Johns Hopkins in 2009 before completing a fellowship in Cardiology at Johns Hopkins in 2012. In 2018, Dr. Blaha received the Dr. Fred Brancati award at Johns Hopkins for excellence in mentoring. He has mentored over 30 trainees, many of which have gone on to hold prominent academic appointments. In 2021, Dr. Blaha was named to the Clarivate Highly Cited Researcher List, representing the top 1% of world’s researchers, and was first named to the Baltimore Magazine Best Doctors List. In 2022, he received the Arthur S. Agatston Cardiovascular Disease Prevention Award. Clinically, he practices as a preventive cardiologist specializing in cardiometabolic disease and in the interpretation of cardiac CT. His clinic specializes in patients with cardiometabolic disease and advanced subclinical atherosclerosis, and the focused use of an array of lifestyle and pharmacotherapies to mitigate that risk. Dr. Blaha is rated as an Elite provider by MediFind in the treatment of Brugada Syndrome. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, High Cholesterol, Metabolic Syndrome, and Percutaneous Coronary Intervention (PCI).

Ankit Shah, DO, is a cardiologist with UPMC Heart and Vascular Institute and is certified in internal medicine by the American Osteopathic Board of Internal Medicine. He received his medical degree from Edward Via College of Osteopathic Medicine and completed his internal medicine residency at Jefferson Health and Mather Hospital, followed by his cardiology fellowship at Rowan University affiliated hospitals including Jefferson Health and Virtua Health. Dr. Shah’s clinical interests include non-invasive cardiology, preventive cardiology, obesity, echocardiography, nuclear studies, electrocardiogram, ultrasounds, vascular studies, cardioversion, and transvenous pacemaker placement. Outside of medicine, Dr. Shah enjoys traveling abroad, hiking, jogging, playing board games, and watching various genres of movies. He is fluent in English, Gujarati, and Hindi. Dr. Shah is rated as an Advanced provider by MediFind in the treatment of Brugada Syndrome. His top areas of expertise are Ectopic Heartbeat, Inappropriate Sinus Tachycardia (IST), Heart Attack, and Familial Ventricular Tachycardia.